» Authors » Vathana Sackett

Vathana Sackett

Explore the profile of Vathana Sackett including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 6
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Roff M, Tian B, Johnston E, Sackett V, Bourke A, Pharande P, et al.
J Paediatr Child Health . 2025 Mar; PMID: 40051191
No abstract available.
2.
Ng N, Razak A, Chandrasekharan P, McLean G, Sackett V, Zhou L, et al.
J Paediatr Child Health . 2024 Aug; 60(11):669-674. PMID: 39183581
Aim: Intraventricular haemorrhage (IVH) and periventricular leukomalacia (PVL) in preterm infants are associated with an increased risk of long-term neurodevelopmental impairments (NDI) and cerebral palsy (CP). However, little is known...
3.
Razak A, Johnston E, Sackett V, Clark M, Charlton M, Zhou L, et al.
JAMA Netw Open . 2024 May; 7(5):e2413550. PMID: 38709738
Importance: Studies suggest that early neurodevelopmental assessments are beneficial for identifying cerebral palsy, yet their effectiveness in practical scenarios and their ability to detect cognitive impairment are limited. Objective: To...
4.
Zhong B, Tan K, Razak A, Sackett V, Machipisa C, Zhou L, et al.
Pediatr Res . 2023 May; 94(5):1714-1719. PMID: 37198403
Background: Paracetamol is commonly used for analgesia and patent ductus arteriosus (PDA) treatment in preterm infants. We aimed to evaluate early neurodevelopmental outcomes of extreme preterm infants exposed to paracetamol...
5.
Hill R, Malhotra A, Sackett V, Williams K, Fahey M, Palmer K, et al.
BMC Pediatr . 2023 Jan; 23(1):48. PMID: 36717903
Background: The Coronavirus disease (COVID-19) pandemic has created unprecedented acute global health challenges. However, it also presents a set of unquantified and poorly understood risks in the medium to long...
6.
Connors R, Sackett V, Machipisa C, Tan K, Pharande P, Zhou L, et al.
Brain Sci . 2022 Jul; 12(7). PMID: 35884654
Background: Early diagnosis of cerebral palsy (CP) in high-risk infants is possible at 3−4 months’ corrected age (CA) using standardised assessments. Aim: To assess the utility of neonatal screening assessments—writhing...